Euthyrox and Yervoy drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Euthyrox (levothyroxine sodium) and Yervoy (ipilimumab). Common drug interactions include muscular weakness among females and pneumonitis among males.

The phase IV clinical study analyzes what interactions people have when they take Euthyrox and Yervoy. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Euthyrox?

Euthyrox has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 8,740 Euthyrox users. Check the latest studies of Euthyrox.

What is Yervoy?

Yervoy has active ingredients of ipilimumab. eHealthMe is studying from 26,662 Yervoy users. Check the latest studies of Yervoy.

On Jul, 12, 2026

14 people who take Euthyrox and Yervoy together, and have interactions are studied.

What are the common drug interactions of Euthyrox and Yervoy, by gender? *:

female:

Muscular weakness (muscle weakness)
Decreased appetite
Fatigue (feeling of tiredness)
Headache (pain in head)
Myocarditis (inflammation of heart muscle myocardium)
Myositis (inflammation of the muscles)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Blood corticotrophin decreased
Encephalopathy (functioning of the brain is affected by some agent or condition)
Fall

male:

Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Diarrhoea
Hyperhidrosis (abnormally increased sweating)
Liver disorder (liver diseases)
Muscular weakness (muscle weakness)
Pyrexia (fever)
Rash
Rash papular (redness with papule)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Upper respiratory tract infection

What are the common drug interactions of Euthyrox and Yervoy, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Muscular weakness (muscle weakness)
Myocarditis (inflammation of heart muscle myocardium)
Myositis (inflammation of the muscles)
Hepatitis (inflammation of the liver)

50-59:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Blood corticotrophin decreased
Decreased appetite
Encephalopathy (functioning of the brain is affected by some agent or condition)
Fall
Fatigue (feeling of tiredness)
Fibrin d dimer increased
Headache (pain in head)
Hypotension (abnormally low blood pressure)
Hypoxia (low oxygen in tissues)

60+:

Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Diarrhoea
Decreased appetite
Eye irritation
Eye pain
Fatigue (feeling of tiredness)
Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli)
Glucocorticoid deficiency (less glucocorticoids secretion from kidney)
Headache (pain in head)
Hyperhidrosis (abnormally increased sweating)

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 4 people, 28.57%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 3 people, 21.43%
Cervix Carcinoma Recurrent (repeated cancer of cervix): 3 people, 21.43%
Malignant Melanoma (skin cancer rises from melancytes): 2 people, 14.29%
Renal Neoplasm (kidney tumour): 1 person, 7.14%
Pneumonia: 1 person, 7.14%
Pleural Mesothelioma Malignant (cancer of the pleura, or the membrane that lines the lungs): 1 person, 7.14%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 1 person, 7.14%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Euthyrox and Yervoy?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously